Paradigm Health delivers greater efficiency, faster patient recruitment, and higher-quality data through a provider and site-friendly infrastructure embedded within the industry’s largest network of community and academic research sites.
Paradigm Health delivers a unified, AI-powered research model for Phase I- IV clinical trials that optimizes protocol design, activates high-performing sites, improves enrollment performance, and automates data capture. We make clinical trials accessible to any patient, anywhere, while reducing the burden on providers.
The Paradigm Health Difference
The Paradigm Health Platform
Our AI-driven platform connects directly with providers’ systems and workflows to accelerate feasibility and patient identification, improve representative enrollment while delivering cleaner, more reliable data trial sponsors faster.
Fully Integrated Provider Network
We are the end-to-end research partner of choice for community healthcare providers and academic medical centers across the United States, Japan, and Israel. Our deep network intelligence enables us to select the best sites for any trial.
Deep Trial Expertise
Our in-house experts, including practicing oncologists, work directly with sponsors to derive rich insights and actionable recommendations from our data and clinical practice.
An End-to-End Solution
Learn More ⬇
Learn More ⬇
Trial Design & Protocol Optimization
Model eligibility criteria against real-world clinical data to quantify how protocol design choices affect the recruitable patient population. Identify adjustments that expand feasibility and reduce the risk of costly amendments before activation.
Feasibility & Site Selection
Evaluate sites using real patient availability, historical performance, and operational insights to identify those most likely to deliver sustained enrollment. Deploy studies where both patient volume and site capability align.
Patient Identification & Enrollment
Automatically identify eligible patients within provider EHR workflows and support sites through screening and enrollment with integrated technology and dedicated CRC support. Reduce manual screening burden at participating sites while expanding the recruitable patient population for your trial.
Recruitment Intelligence
Monitor recruitment performance across sites with real-time visibility into screening volume, eligibility rates, and enrollment progress. Identify bottlenecks early and optimize site recruitment strategy across the Paradigm Health network.
.png)
Integrated Source Data Capture
Capture clinical trial data from EHR systems and clinical documentation while enabling study teams to enter protocol-specific data through Direct Data Capture forms accessible within the EHR or through a standalone application, reducing manual entry and improving data quality.
Source Data Verification & Monitoring
Enable more efficient monitoring and data review through source-linked eCRFs, automated traceability, and integrated source viewers that allow monitors to validate trial data directly against the originating clinical record, reducing manual verification while streamlining delivery to EDC systems.
Embedded Study Conduct Workflows
Support research teams with integrated workflows that guide protocol activities, streamline investigator oversight, and reduce operational burden, making studies easier to run and delivering a better experience for sites.
A proven partner to execute your evidence strategy
Paradigm Health is rebuilding trial delivery for the demands of modern late phase and post approval research with advanced AI and site-based technology.
We offer full-service support for the design and execution of late-phase interventional, observational, and pragmatic trials, including protocol design, start-up, execution, and close-out.
Paradigm Health delivers fit-for-purpose evidence with greater reliability, improved efficiency, and reduced burden for sites and patients.
Paradigm Health’s Clinical Trial Network
6.5x faster enrollment
Multiple Myeloma trial: Paradigm Health's approach led to enrollment that was ~20-30% cheaper and ~6.5x faster compared to traditional approaches.
25+ sites identified
Triple-negative breast cancer trial: Paradigm Health identified 27 US community oncology sites with a high volume of racially and ethnically diverse potentially eligible patients.
>10% of total trial enrollment
Ph II ultra-rare disease basket trial: Over 10% of total trial enrollment was driven by Paradigm Health, including the first-patient-in on one of the rare, biomarker-defined trial arms.
Paradigm Health has successfully collaborated with leading industry sponsors, including Bristol-Myers Squibb (BMS), to support mission-critical research programs.
